Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 321–340 of 17,683 recalls
Cipla USA, Inc.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Lupin Pharmaceuticals Inc.
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.